Twenty‐Year Follow‐Up After Pediatric PBSCT and Living‐Donor Lung Transplantation From the Original Donor: Late Benefit of Belumosudil for Chronic GVHD
Abstract
The authors declare no conflicts of interests.
Like
Bookmark
Share
Like
Bookmark
Share
Twenty‐Year Follow‐Up After Pediatric PBSCT and Living‐Donor Lung Transplantation From the Original Donor: Late Benefit of Belumosudil for Chronic GVHD | Synapse